IP Library Granted Patent US 10,761,096
Granted Patent B2
US 10,761,096 · App. 16/299,667 · Granted Sep 1, 2020

Quantitative peptide or protein assay

Inventors: Paul Jeffrey Haney (Beloit, WI); Christopher L. Etienne (Oregon, WI); Sijian Hou (Rockford, IL); Erum Raja (Rockford, IL); Ramesh Ganapathy (Loves Park, IL)
Assignee: Pierce Biotechnology, Inc.
G01N33/6833G01N33/6839G01N2560/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,761,096
App. No.
16/299,667
Granted
Sep 1, 2020
Kind
B2
Abstract

Peptide and/or protein quantitation methods, kits, and compositions, particularly useful for mass spectrometry, are provided herein based on a bathocuproine-based composition complex such as bathocuproinedisulfonic acid disodium salt hydrate complex. The methods are one-step rapid absorbance methods using small sample volumes. They produce a robust signal with high signal to background ratio and accurately quantitate even complex peptide mixtures with low variability and high sensitivity.

Claims (46)

1. A direct method for determining peptide or protein concentration in a sample, the method for determining peptide or protein concentration comprising

(a) combining the sample with a quantitation assay reagent composition comprising copper sulfate, acetonitrile present at a concentration ranging from about 10% to about 50%, and a complex to form a mixture, wherein the complex contains the formula:

wherein

each of R 1 and R 2 is independently chosen from C 1 -C 6 straight and branched alkyls, and C 6 -C 20 aryl, alkylaryl, and arylalkyls;

each of R 3 and R 4 is independently chosen from the group consisting of hydrogen; a sulfonate salt chosen from a salt of sodium, potassium, and lithium; a phosphonate salt chosen from a salt of sodium, potassium, and lithium; and a carboxylate salt chosen from a salt of sodium, potassium, and lithium; and

each of R 5 and R 6 is

 wherein R 7 is independently chosen from the group consisting of hydrogen; sulfonate salts chosen from sodium, potassium, and lithium; phosphonate salts chosen from sodium, potassium, and lithium; and carboxylate salts chosen from sodium, potassium, and lithium;

with the proviso that at least one of R 3 , R 4 , and R 7 is not H;

(b) incubating the mixture under conditions sufficient to form a colored complex; and

(c) measuring absorbance of the colored complex at a wavelength ranging from 450 nm to 500 nm, wherein the amount of colored complex measured is directly proportional to peptide or protein concentration in the sample.

2. The method of claim 1 , wherein the reagent composition in (a) further comprises tartrate and sodium bicarbonate.

3. The method of claim 1 , further comprising, after step (c), determining the peptide or protein concentration in the sample by comparing the measured absorbance of step (c) with an absorbance of at least one sample containing a known concentration of a standard, wherein the absorbance of the at least one sample containing a known concentration is measured at a wavelength ranging from 450 nm to 500 nm.

4. The method of claim 3 , wherein the standard comprises at least one entity chosen from peptides, peptide mixtures, and peptide digests at a known concentration.

5. The method of claim 1 , wherein the incubation conditions are chosen from a range of from room temperature to about 45° C.; a range of from about 19° C. to about 22° C.; about 37° C.; and about 45° C.

6. The method of claim 5 , wherein the incubation conditions range from about 19° C. to about 22° C.

7. The method of claim 6 , wherein the incubation conditions are about 37° C.

8. The method of claim 1 , wherein mass spectrometry analysis of the sample is performed after step (c).

9. The method of claim 1 , wherein the quantitation assay reagent composition comprises bathocuproinedisulfonic acid disodium salt hydrate with about 50% acetonitrile.

10. A direct method for determining peptide or protein concentration in a sample, the method for determining peptide or protein concentration comprising

(a) combining the sample with a quantitation assay reagent composition comprising copper sulfate, acetonitrile present at a concentration ranging from about 10% to about 50%, and a complex to form a mixture, wherein the complex contains bathocuproinedisulfonic acid disodium salt hydrate:

(b) incubating the mixture under conditions sufficient to form a colored complex; and

(c) measuring absorbance of the colored complex at a wavelength ranging from 450 nm to 500 nm, wherein the amount of colored complex measured is directly proportional to peptide or protein concentration in the sample.

11. The method of claim 10 , further comprising, after step (c), determining the peptide or protein concentration in the sample by comparing the measured absorbance of step (c) with an absorbance of at least one sample containing a known concentration of a standard, wherein the absorbance of the at least one sample containing a known concentration is measured at a wavelength ranging from 450 nm to 500 nm.

12. The method of claim 11 where the standard comprises at least one entity chosen from peptides, peptide mixtures, and peptide digests at a known concentration.

13. The method of claim 10 , wherein the reagent composition in (a) further comprises tartrate.

14. The method of claim 10 , wherein the reagent composition in (a) further comprises sodium bicarbonate.

15. The method of claim 13 , wherein the tartrate is sodium tartrate.

16. The method of claim 10 , wherein the incubation conditions range from room temperature to about 45° C.

17. The method of claim 16 , where the incubation conditions range from about 19° C. to about 22° C.

18. The method of claim 16 , where the incubation conditions are about 37° C.

19. The method of claim 10 , wherein the sample volume ranges from about 5 μl to about 20 μl.

20. The method of claim 10 , wherein the sample comprises a plurality of peptides.

21. The method of claim 10 , wherein the absorbance is measured by an automated microplate reader.

22. The method of claim 10 , wherein the sample is in at least one additional solvent chosen from aqueous solvents and organic solvents.

23. The method of claim 10 , further comprising, after step (c), analyzing the sample by mass spectrometry.

24. The method of claim 10 , wherein the quantitation assay reagent composition further comprises at least one component chosen from detergents and additional organic solvents.

25. A direct method for determining peptide or protein concentration in a sample, the method comprising

(a) combining the sample with a quantitation assay reagent composition comprising

50% acetonitrile and

a complex containing bathocuproinedisulfonic acid disodium salt hydrate:

(b) incubating the mixture under conditions sufficient to form a colored complex; and

(c) measuring absorbance of the colored complex at a wavelength ranging from 450 nm to 500 nm, wherein the amount of colored complex measured is directly proportional to peptide or protein concentration in the sample.

26. The method of claim 25 , further comprising, after step (c), determining the peptide or protein concentration in the sample by comparing the measured absorbance of step (c) with an absorbance of at least one sample containing a known concentration of a standard, wherein the absorbance of the at least one sample containing a known concentration is measured at a wavelength ranging from 450 nm to 500 nm.

27. The method of claim 25 , wherein the reagent composition in step (a) further comprises tartrate and copper sulfate.

28. The method of claim 25 , further comprising, after step (c), analyzing the sample by mass spectrometry.

29. The method of claim 26 , wherein the standard comprises at least one entity chosen from peptides, peptide mixtures, and peptide digests at a known concentration.

Assignments (2)
MERGER Recorded Mar 11, 2026
From: PIERCE BIOTECHNOLOGY, INC.
To: LIFE TECHNOLOGIES CORPORATION
Reel/Frame 075052/0213 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 19, 2019
From: HANEY, PAUL JEFFREY; ETIENNE, CHRISTOPHER L.; HOU, SIJIAN; RAJA, ERUM; GANAPATHY, RAMESH
To: PIERCE BIOTECHNOLOGY, INC.
Reel/Frame 048935/0694 →
Continuity (4)
Division 15674831 · Aug 11, 2017
Division 14734678 · Jun 9, 2015
Provisional Application 62010594 · Jun 11, 2014
Related Publication 20190195885A1 · Jun 27, 2019